Johnson & Johnson vs Western Alliance Bancorporation — how do they compare? Johnson & Johnson trades at $258.02 (market cap $626.09B), while Western Alliance Bancorporation trades at $81.55 (market cap $8.89B). The key difference: Johnson & Johnson is far larger — about 70.4× Western Alliance Bancorporation's market cap, and Johnson & Johnson is trading nearer its 52-week high, Western Alliance Bancorporation nearer its low. Which is the better fit depends on your goals.
| JNJ | WAL | |
|---|---|---|
Market Cap | $626.09B | $8.89B |
Volume | 6,156,228 | — |
Sector | Health | Financials |
52-Week High | $267.24 | $96.08 |
52-Week Low | $172.78 | $66.70 |
Enterprise Value | $654.37B | — |
Dividend Yield | 2.06% | 2.06% |
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $261.81, up 0.99% on the day and near its 52-week high. The stock exhibits bullish technical signals with strong moving average support, while fundamentals show robust profitability with a net income margin of 21.48% and consistent dividend growth. Recent earnings have mostly beaten expectations, and the company maintains a solid balance sheet with $24.52 billion in cash.
The outlook for JNJ remains positive, supported by analyst consensus and a price target of $284.50. Key opportunities include its defensive healthcare positioning and pipeline strength, though risks involve patent expirations and legal headwinds. The stock offers a stable investment with growth potential in a volatile market.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →Western Alliance Bancorporation is a top-performing bank holding company that operates a dual business model: high-touch regional banking and specialized national business lines. It serves niche industries—including technology, life sciences, and homeowners associations—providing sophisticated commercial lending and treasury solutions that bridge the gap between regional service and national scale.
Read more on WAL →